REVOLUTIONIZING THE DIAGNOSIS OF
INFLAMMATORY
BOWEL DISEASES
We pioneer non-invasive stool tests, leveraging patient transcriptome & an AI-driven classifier, for advanced transcriptomics and precise diagnostics of inflammatory bowel diseases.
OUR MISSION
TRACELL'S PRECISION DIAGNOSIS
Non-Invasive Stool Testing for Accurate Detection and Characterization of Inflammation
Tracells' stool test utilizes RNA profiles from patients' intestinal cells, which are shed into the stool, for accurate IBD diagnosis.
The AI-driven analysis offers insights into inflammation severity, location, and probabilities to response to diverse therapies.
IBD DIAGNOSIS IS CHALLENGING
Current non-invasive blood and fecal tests lack specificity for IBD diagnosis and cannot pinpoint inflammation locations, necessitating invasive diagnostic procedures.
Achieving endoscopic remission, a key treatment goal for IBD, currently requires invasive methods like endoscopies and biopsies.
There is a pressing need for accurate non-invasive methods to diagnose IBD
ADVANCED BOWEL INFLAMMATION MAPPING
The Benefits of Inflammation Characterization via Stool Testing:
PERSONAL THERAPY
Capture colonoscope equivalent biometric data
CONVENIENCE
Home-based stool test, decreasing reliance on invasive procedures
PRECISION
~1000-gene analysis for highly accurate diagnosis
MONITORING
Non-invasive & budget-friendly, allowing for regular tracking in proactive disease management
PATENT
Utilizes licensed patented technology that increases signal over noise
